V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006628 | 290004991 | 1.6 | 100 | null | 2018-09-07 | 2018-09-13 | CARBOPLATIN + PACLITAXEL | null | N | 290020014 | MITOMYCIN |
| 290006629 | 290004992 | 1.67 | 80.9 | Palliative (P) | 2015-04-06 | 2015-04-06 | LANREOTIDE | 02 | N | 290020036 | INTERAACT TRIAL |
| 290006630 | 290004993 | 1.71 | 70 | Palliative (P) | 2016-07-22 | 2016-07-22 | Cisplatin 100 + RT(H&N) 1 day | N | N | 290020038 | CAPECITABINE |
| 290006631 | 290004994 | 1.9 | 72.6 | Palliative (P) | 2016-08-23 | 2016-10-09 | PERTUZUMAB + TRASTUZUMAB | 2 | N | 290020041 | CETUXIMAB + CISPLATIN + FU |
| 290006632 | 290004995 | 1.5 | null | Curative (C) | 2015-11-28 | 2015-12-27 | CAPECITABINE + MITOMYCIN + RT | N | Y | 290020046 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006633 | 290004996 | 1.69 | 52.6 | Palliative (P) | 2015-12-29 | 2016-01-19 | LANREOTIDE | N | N | 290020049 | IRINOTECAN |
| 290006634 | 290004998 | null | 77 | null | 2014-06-24 | 2014-11-16 | BCG Intravesical | 2 | Y | 290020064 | CAPECITABINE + OXALIPLATIN |
| 290006635 | 290004999 | null | 76.2 | Disease modification (D) | 2014-07-10 | 2014-07-10 | Cetuximab + Radiotherapy Maint | N | N | 290020067 | SUNITINIB |
| 290006636 | 290005000 | 1.81 | 77.7 | Palliative (P) | 2016-04-21 | 2016-04-27 | CETUXIMAB | N | N | 290020072 | CARBOPLATIN + ETOPOSIDE |
| 290006637 | 290005000 | null | 61 | null | 2017-02-13 | 2017-02-21 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 290020072 | TRIAL |
| 290006638 | 290005001 | null | 90 | Palliative (P) | 2013-06-14 | 2013-07-26 | EVEROLIMUS | N | N | 290020083 | SUNITINIB |
| 290006639 | 290005002 | 1.61 | null | Palliative (P) | null | 2015-11-05 | CAPECITABINE + CISPLATIN + EPIRUBICIN | N | N | 290020090 | IRINOTECAN |
| 290006640 | 290005004 | null | null | Curative (C) | 2017-11-18 | 2017-11-18 | Capecitabine + Cisplatin | N | null | 290020091 | CARBOPLATIN + RT |
| 290006641 | 290005005 | 0 | null | Adjuvant (A) | 2017-08-08 | 2018-02-24 | CAPECITABINE + MITOMYCIN + RT | N | N | 290020094 | CAPECITABINE + RT |
| 290006642 | 290005005 | 1.67 | 66 | Palliative (P) | 2016-04-17 | 2016-04-20 | Capecitabine (14 days)+Carboplatin | 2 | N | 290020094 | CISPLATIN + GEMCITABINE |
| 290006643 | 290005005 | 1.74 | null | Curative (C) | 2014-12-06 | 2014-12-27 | MCX | N | Y | 290020094 | CAPECITABINE + MITOMYCIN |
| 290006644 | 290005005 | null | 53.7 | Curative (C) | null | 2016-01-22 | Capecitabine + Cisplatin | N | null | 290020094 | CETUXIMAB |
| 290006645 | 290005005 | 1.56 | 72.6 | Palliative (P) | 2013-06-15 | 2013-06-16 | Capecitabine + Oxaliplatin 21day | 2 | N | 290020094 | SUNITINIB |
| 290006646 | 290005006 | 1.89 | 109 | Curative (C) | 2016-06-26 | 2016-06-27 | MITOMYCIN | N | Y | 290020146 | CAPECITABINE + MITOMYCIN + RT |
| 290006647 | 290005006 | 1.59 | 58 | Adjuvant (A) | 2017-11-05 | 2018-01-17 | Bevacizumab 7.5mg/kg | N | N | 290020146 | CISPLATIN + RT |
| 290006648 | 290005007 | null | 58.4 | Palliative (P) | null | 2013-08-03 | EOX | N | Y | 290020154 | ECX |
| 290006649 | 290005008 | 1.7 | 72.7 | Adjuvant (A) | 2015-08-27 | 2017-09-10 | Carboplatin AUC 6 - 10 | N | N | 290020156 | CAPECITABINE |
| 290006650 | 290005009 | null | null | Curative (C) | null | 2014-07-23 | PEMBROLIZUMAB | null | null | 290020156 | CISPLATIN |
| 290006651 | 290005013 | 1.5 | 83 | Curative (C) | 2016-06-07 | 2017-03-28 | METHOTREXATE | 02 | N | 290020172 | R-EPOCH |
| 290006652 | 290005014 | null | null | Not known (9) | 2017-08-27 | 2017-09-28 | Capecitabine 35days + RT | N | N | 290020188 | FLUOROURACIL + MITOMYCIN |
| 290006653 | 290005017 | 1.6 | 90.2 | Curative (C) | 2016-08-01 | 2016-08-01 | LANREOTIDE | 2 | Y | 290020194 | CAPECITABINE + MITOMYCIN + RT |
| 290006654 | 290005018 | null | 77.7 | Palliative (P) | 2019-01-01 | 2019-01-01 | Cisplatin + Radiotherapy | 02 | N | 290020209 | CETUXIMAB + CISPLATIN + FU |
| 290006655 | 290005019 | 1.47 | 82.9 | Palliative (P) | 2013-05-06 | 2013-05-13 | Gemcitabine weekly | 2 | N | 290020212 | CARBOPLATIN + PACLITAXEL |
| 290006656 | 290005021 | 1.64 | 90.2 | Palliative (P) | 2017-02-03 | 2017-02-27 | Gemcitabine weekly | N | N | 290020218 | CAPECITABINE + CISPLATIN |
| 290006657 | 290005022 | 1.6 | 100.65 | Curative (C) | null | 2015-01-10 | Sunitinib | null | null | 290020225 | CISPLATIN + RT |
| 290006658 | 290005023 | null | 65.2 | null | 2016-01-10 | 2016-01-15 | Ralitrexed | N | null | 290020225 | CISPLATIN |
| 290006659 | 290005023 | 1.63 | 55.6 | Adjuvant (A) | 2019-01-10 | 2019-01-17 | CARBOPLATIN + RT | 2 | N | 290020225 | CAPECITABINE + OXALIPLATIN |
| 290006660 | 290005023 | null | 72.7 | Palliative (P) | 2015-08-21 | 2015-08-25 | Capecitabine | 02 | N | 290020225 | MCX |
| 290006661 | 290005024 | 1.74 | 87 | Palliative (P) | 2017-05-14 | 2017-08-22 | Capecitabine | 2 | Y | 290020243 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290006662 | 290007115 | 1.67 | 94.4 | Adjuvant (A) | 2014-10-04 | 2014-10-20 | Capecitabine | 2 | N | 290020248 | CISPLATIN |
| 290006663 | 290005026 | 1.57 | 46 | Disease modification (D) | 2017-02-23 | 2017-03-19 | CISPLATIN + RT | 2 | Y | 290020254 | SUNITINIB |
| 290006664 | 290005027 | 1.82 | 74.8 | Adjuvant (A) | 2016-12-24 | 2017-01-14 | REGORAFENIB | N | N | 290020264 | TRIAL |
| 290006665 | 290005028 | null | 66.8 | Neo-adjuvant (N) | 2018-10-11 | 2018-11-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020268 | CAPECITABINE |
| 290006666 | 290005029 | 1.72 | 41 | Adjuvant (A) | null | 2016-11-18 | LANREOTIDE | N | Y | 290020270 | CAPECITABINE |
| 290006667 | 290005030 | 1.8 | 79.3 | Palliative (P) | 2016-02-12 | 2016-02-12 | VDC | N | Y | 290020272 | TRASTUZUMAB + VINORELBINE |
| 290006668 | 290005030 | 1.5 | 93 | Curative (C) | 2017-07-26 | 2017-07-26 | Fluorouracil PVI + Mitomycin 42 day | 02 | N | 290020272 | COMPARE TRIAL |
| 290006669 | 290005032 | 1.69 | 74.2 | Palliative (P) | 2014-03-12 | 2014-03-15 | OCTREOTIDE | 02 | N | 290020284 | EVEROLIMUS |
| 290006670 | 290005033 | 1.52 | 50.4 | Palliative (P) | 2017-03-05 | 2017-07-23 | Cisplatin + Radiotherapy | 02 | N | 290020300 | CARBOPLATIN + PACLITAXEL |
| 290006671 | 290005034 | 1.52 | 73 | Curative (C) | 2018-02-06 | 2018-02-07 | Capecitabine + Mitomycin | 02 | null | 290020310 | VDC |
| 290006672 | 290007119 | null | 99 | Palliative (P) | 2017-05-25 | 2017-06-21 | null | N | N | 290020320 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290006673 | 290005035 | 1.52 | 61.1 | Curative (C) | 2017-08-15 | 2017-08-19 | Capecitabine + Cisplatin | N | N | 290020321 | CETUXIMAB + CISPLATIN + FU |
| 290006674 | 290005036 | 1.69 | 95 | Curative (C) | 2015-04-25 | 2015-05-24 | CETUXIMAB | N | Y | 290020325 | CARBOPLATIN + RT |
| 290006675 | 290007120 | null | 62.75 | Palliative (P) | 2017-05-13 | 2017-05-21 | Oxaliplatin + Raltitrexed | 99 | null | 290020327 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290006676 | 290005037 | 2 | 104.2 | Palliative (P) | 2015-11-24 | 2015-12-03 | CHOP | 02 | null | 290020329 | EVEROLIMUS |
| 290006677 | 290005037 | 1.71 | 67.4 | Curative (C) | 2017-05-24 | 2017-07-11 | Melphalan IV High dose | Y | N | 290020329 | CETUXIMAB |